1011 related articles for article (PubMed ID: 34502029)
1. Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.
Pradip D; Jennifer A; Nandini D
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502029
[TBL] [Abstract][Full Text] [Related]
2. A CAF-Based Two-Cell Hybrid Co-Culture Model to Test Drug Resistance in Endometrial Cancers.
Sulaiman R; De P; Aske JC; Lin X; Dale A; Gaster K; Espaillat LR; Starks D; Dey N
Biomedicines; 2023 Apr; 11(5):. PubMed ID: 37238998
[TBL] [Abstract][Full Text] [Related]
3. Addressing activation of WNT beta-catenin pathway in diverse landscape of endometrial carcinogenesis.
De P; Aske JC; Dale A; Rojas Espaillat L; Starks D; Dey N
Am J Transl Res; 2021; 13(11):12168-12180. PubMed ID: 34956444
[TBL] [Abstract][Full Text] [Related]
4. HIPK2 role in the tumor-host interaction: Impact on fibroblasts transdifferentiation CAF-like.
Garufi A; Traversi G; Cirone M; D'Orazi G
IUBMB Life; 2019 Dec; 71(12):2055-2061. PubMed ID: 31414572
[TBL] [Abstract][Full Text] [Related]
5. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
7. Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance.
De P; Aske J; Sulaiman R; Dey N
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326670
[TBL] [Abstract][Full Text] [Related]
8. A landscape of patient-derived cancer-associated fibroblast signals in endometrial cancers.
Sulaiman R; Koirala N; Aske JC; Lin X; Rojas-Espaillat L; Starks D; Dale A; Gaster K; De P; Dey N
Am J Cancer Res; 2024; 14(2):467-489. PubMed ID: 38455423
[TBL] [Abstract][Full Text] [Related]
9. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):340-351. PubMed ID: 32496971
[TBL] [Abstract][Full Text] [Related]
10. Tumor-TME Bipartite Landscape of PD-1/PD-L1 in Endometrial Cancers.
Sulaiman R; De P; Aske JC; Lin X; Dale A; Koirala N; Gaster K; Espaillat LR; Starks D; Dey N
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446260
[TBL] [Abstract][Full Text] [Related]
11. A review on the role of CAFs and CAF-derived exosomes in progression and metastasis of digestive system cancers.
Zarin B; Rafiee L; Daneshpajouhnejad P; Haghjooy Javanmard S
Tumour Biol; 2021; 43(1):141-157. PubMed ID: 34420992
[TBL] [Abstract][Full Text] [Related]
12. Versatility of Cancer Associated Fibroblasts: Commendable Targets for Anti-tumor Therapy.
Khan GJ; Sun L; Khan S; Yuan S; Nongyue H
Curr Drug Targets; 2018; 19(13):1573-1588. PubMed ID: 29468965
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies.
Mhaidly R; Mechta-Grigoriou F
Semin Immunol; 2020 Apr; 48():101417. PubMed ID: 33077325
[TBL] [Abstract][Full Text] [Related]
14. Cancer-Associated Fibroblast Functions as a Road-Block in Cancer Therapy.
De P; Aske J; Dey N
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680395
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in the Pancreatic Cancer Tumor Microenvironment-The Double-Edged Sword of Cancer-Associated Fibroblasts.
Pfeifer E; Burchell JM; Dazzi F; Sarker D; Beatson R
Cells; 2021 Jul; 10(7):. PubMed ID: 34359823
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblasts: Is it a key to an intricate lock of tumorigenesis?
Aden D; Zaheer S; Ahluwalia H; Ranga S
Cell Biol Int; 2023 May; 47(5):859-893. PubMed ID: 36871165
[TBL] [Abstract][Full Text] [Related]
17. A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer.
Bonneau C; Eliès A; Kieffer Y; Bourachot B; Ladoire S; Pelon F; Hequet D; Guinebretière JM; Blanchet C; Vincent-Salomon A; Rouzier R; Mechta-Grigoriou F
Breast Cancer Res; 2020 Jul; 22(1):76. PubMed ID: 32665033
[TBL] [Abstract][Full Text] [Related]
18. Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.
Zou R; Jiang Q; Jin T; Chen M; Yao L; Ding H
Front Immunol; 2022; 13():956224. PubMed ID: 36032075
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts: Just on the opposite side of antitumour immunity?
Guo S; Yuan J; Meng X; Feng X; Ma D; Han Y; Li K
Int Immunopharmacol; 2023 Sep; 122():110601. PubMed ID: 37418988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
